INSULINE ASPARTE SANOFI 100 units/ml, solution for injection in a vial bottle, 10 ml
Active ingredients: Insulin aspart
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 10 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INSULINE ASPARTE SANOFI 100 unités/ml, solution injectable en flacon
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre multidose(s) de 10 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Dec 2021
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
65805841CIP73023393CIP133400930233931Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INSULINE ASPARTEsolution | 100 unités · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.